Cytek Biosciences CTKB
NASDAQ CTKB
$5.81 -0.15 (-2.52%)
At close: Oct 1, 2026 · 4:00 PM EDT

Cytek Biosciences (CTKB) Liabilities and Shareholders Equity (2020 - 2026)

Updated

Cytek Biosciences (CTKB) reported Liabilities and Shareholders Equity of $446.93 million for Q2 2026, down 9.4% from $493.32 million a year earlier and down 0.5% from the prior quarter.

Analysis

Cytek Biosciences (CTKB) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, Cytek Biosciences posted Liabilities and Shareholders Equity of $461.54 million, down 7.6% from FY2024.

  • Liabilities and Shareholders Equity has a five-year compound annual growth rate of 16.0% (FY2020 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $499.5 million in FY2024 (+1.0%), $494.46 million in FY2023 (-4.8%), $519.48 million in FY2022 (+12.1%) and $463.31 million in FY2021 (+110.6%).
  • The Q2 2026 figure ranks as the lowest quarterly Liabilities and Shareholders Equity since Q2 2021.
  • Year over year, Liabilities and Shareholders Equity has now declined in each of the last three quarters, with an average decline of 3.4% over the last eight quarters.
  • The high point for year-over-year Liabilities and Shareholders Equity in five years was Q2 2022 (growth of 114.0%); the low point was Q2 2026 (a decline of 9.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $449.11 million (Q1 2026), $461.54 million (Q4 2025) and $494.92 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 113.17 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 109.22 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 92.37 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 20.88 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 93.31 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 47.93 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 45.22 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 13.87 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 50.73 Bn
10 Cytek Biosciences 774.70 Mn 450.97 Mn 28.34 Mn 446.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 446.93 Mn
Mar 31, 2026 449.11 Mn
Dec 31, 2025 461.54 Mn
Sep 30, 2025 494.92 Mn
Jun 30, 2025 493.32 Mn
Mar 31, 2025 482.60 Mn
Dec 31, 2024 499.50 Mn
Sep 30, 2024 491.23 Mn
Jun 30, 2024 483.73 Mn
Mar 31, 2024 492.07 Mn
Dec 31, 2023 494.46 Mn
Sep 30, 2023 519.43 Mn
Jun 30, 2023 525.05 Mn
Mar 31, 2023 524.58 Mn
Dec 31, 2022 519.48 Mn
Sep 30, 2022 499.30 Mn
Jun 30, 2022 492.82 Mn
Mar 31, 2022 485.88 Mn
Dec 31, 2021 463.31 Mn
Sep 30, 2021 454.32 Mn
API Access

Cytek Biosciences Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CTKB&period=max&api_key=YOUR_API_KEY